HNRNPK and breast carcinoma: In another research study, it was reported that Embelin reduced the levels of the TNF-α converting enzyme levels in human breast cancer cells through inhibition of MMPs (Matrix metalloproteinases), VEGF (Vascular Endothelial Growth Factor) and hnRNP-K (Heterogeneous nuclear ribonucleoprotein K) molecules in breast cancer cells (MCF 7 and MDA-MB-231 cells).